MyFinsight
Home
Blog
About
Contact
Proceeds from sales and
maturities of investments
$19,500K
Net cash provided by
(used in) investing...
$19,500K
Net (decrease)
increase in cash and cash...
$9,083K
Canceled cashflow
$10,417K
Accounts payable
$2,390K
Stock-based compensation
expense
$1,447K
Noncash rent expense
$546K
Other non-current
assets
-$44K
Depreciation expense
$27K
Net cash provided by
(used in) operating...
-$10,232K
Net cash provided by
financing activities
-$185K
Canceled cashflow
$4,454K
Net income (loss)
-$9,036K
Accrued expenses and
other current...
-$3,587K
Proceeds from exercise of
common stock options...
-$185K
Non-current operating lease
liabilities
-$980K
Prepaid expenses and
other current assets
$921K
(accretion) amortization on
investments
$162K
Back
Back
Cash Flow
Black Diamond Therapeutics, Inc. (BDTX)
Black Diamond Therapeutics, Inc. (BDTX)
source: myfinsight.com